典型文献
针刺治疗慢性鼻窦炎及术后疼痛的网状Meta分析
文献摘要:
Background:The network meta-analysis system was used to evaluate the efficacy of various acupuncture and moxibustion techniques for chronic rhinosinusitis(CRS)and related postoperative pain.Methods:An electronic search of PubMed,Embase,Web of Science,Cochrane Library,OVID(the Offshore Vessel Inspection Database),CNKI,Wanfang,VIP,and CBM databases was conducted to identify ran-domised controlled trials on acupuncture and moxibustion for CRS and related postoperative pain from database inception to February 2021.The study included randomised controlled trials(RCTs)published in China and other countries in languages limited to Chinese and English.Primary studies included treated individuals without limitations on age,gender,or nationality and diagnosed as CRS.The total effective rate,visual analogue scale(VAS)score,and symptom and sign score were the primary outcomes.Evi-dence quality and risk-of-bias were determined.Network meta-analysis was performed.Results:Nineteen articles were included,involving 11 types of intervention measures.The pairwise com-parisons showed that both acupuncture therapy combined with drugs(ATD)and sphenopalatine ganglion acupuncture combined with drugs(SGAD)were superior to western medicine(WM)in improving the to-tal effective rate,and ATD was superior to manual acupuncture therapy(MAT),WM,and placebo(PL).In reducing the VAS score,both ATD and SGAD were superior to WM.Point-through-point acupuncture com-bined with pricking blood therapy(PABT)was superior to MAT.In reducing symptom and sign score,ATD was superior to WM and PL PABT was superior to MAT.The results of network meta-analysis showed that ATD was superior to MAT,Traditional Chinese medicine(TCM),and WM in improving the total effective rate.In reducing the symptom and sign score,ATD was superior to PL,WM,MAT,and sham acupuncture(SA).PL was superior to MAT,WM,and SA.and PABT was superior to MAT and SA,MAT was superior to WM.There was no significant difference between the intervention measures in reducing the VAS score.The surface under the cumulative ranking curve showed that ATD had the best effect in improving the total effective rate and reducing the VAS and symptom and sign score.Conclusion:ATD was the best method for improving the total effective rate and reducing the VAS and symptom and sign score in the treatment of CRS and related postoperative pain.However,considering the current study quantity and quality,multicentre and high-quality clinical studies with larger sample sizes are needed to verify our findings.
文献关键词:
中图分类号:
作者姓名:
秦玲利;蒋磊;李显;朱雪莹;蔡丽珍;胡光迪;孙唯嘉;梁晓;张允岭;张路
作者机构:
中国中医科学院西苑医院,北京100091,中国;汉诺威医科大学康复医学科,汉诺威30625,德国;北京中医药大学,北京100029,中国
文献出处:
引用格式:
[1]秦玲利;蒋磊;李显;朱雪莹;蔡丽珍;胡光迪;孙唯嘉;梁晓;张允岭;张路-.针刺治疗慢性鼻窦炎及术后疼痛的网状Meta分析)[J].世界针灸杂志(英文版),2022(02):89-100
A类:
domised,Evi,parisons,sphenopalatine,SGAD,pricking,PABT
B类:
针刺治疗,慢性鼻窦炎,术后疼痛,Background,network,meta,analysis,system,was,used,evaluate,efficacy,various,acupuncture,moxibustion,techniques,chronic,rhinosinusitis,CRS,related,postoperative,pain,Methods,An,electronic,search,Embase,Cochrane,Library,OVID,Offshore,Vessel,Inspection,Database,Wanfang,VIP,CBM,databases,conducted,identify,controlled,trials,from,inception,February,study,included,randomised,RCTs,published,China,other,countries,languages,limited,Chinese,English,Primary,studies,treated,individuals,without,limitations,gender,nationality,diagnosed,total,effective,rate,visual,analogue,scale,VAS,score,symptom,were,primary,outcomes,dence,quality,risk,bias,determined,Network,performed,Results,Nineteen,articles,involving,types,intervention,measures,pairwise,showed,that,both,therapy,combined,drugs,ATD,ganglion,superior,western,medicine,WM,improving,manual,MAT,placebo,PL,reducing,Point,through,point,blood,results,Traditional,TCM,sham,SA,There,significant,difference,between,surface,under,cumulative,ranking,curve,had,best,Conclusion,method,treatment,However,considering,current,quantity,multicentre,high,clinical,larger,sample,sizes,are,needed,verify,our,findings
AB值:
0.40376
相似文献
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。